Evidence map›Paper›PMID 23178819›Full record

ReviewInternational journal for parasitology2013

Translatability of helminth therapy in inflammatory bowel diseases.

Joel V Weinstock, David E Elliott

Open access · greenAbstract readReview
In one paragraph

Review in International journal for parasitology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Frontiers in immunology · 2026
    Review
  4. Review
  5. Prevalence of Anti-Pathogens (Basel, Switzerland) · 2025
    Article
  6. Current research in parasitology & vector-borne diseases · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joel V WeinstockDivision of Gastroenterology, Tufts Medical Center, Boston, MA, USA. jweinstock2@tuftsmedicalcenter.org
David E Elliott
Tufts Medical Center · USUniversity of Iowa · US

Funding

Helminthic Protection From IBDR01DK058755 · NIDDK · UNIVERSITY OF IOWA · PI WEINSTOCK, JOEL VINCENT · 2001 to 2013
$4.1M
Induction of Regulatory T Cells to Control IBDR01DK091987 · NIDDK · TUFTS MEDICAL CENTER · PI WEINSTOCK, JOEL VINCENT · 2011 to 2014
$1.4M
Helminthic Protection From IBDR56DK058755 · NIDDK · TUFTS MEDICAL CENTER · PI WEINSTOCK, JOEL VINCENT · 2009 to 2009
$485k
NIDDK NIH HHS DK058755NIDDK NIH HHS DK091987NIDDK NIH HHS R01 DK058755NIDDK NIH HHS R01 DK091987NIDDK NIH HHS R56 DK058755
6 · The paper itself

Abstract

Modern hygienic lifestyles are associated with the emergence of inflammatory bowel disease (IBD) which now afflicts millions of people in highly-developed countries. Meticulous hygiene interrupts conduits of transmission required for ubiquitous exposure to parasitic worms (helminths). We proposed that loss of exposure to helminths permits development of IBD. Early clinical trials suggested that exposure to helminths such as Trichuris suis or Necator americanus can improve IBD. Over the last several years, processes to "medicinalize"T. suis have been developed and use of this helminth is now being studied in large multi-center clinical trials. Concurrently, we and others have identified some of the immune regulatory mechanisms elicited by helminth exposure that suppress inappropriate intestinal inflammation. These efforts could soon result in new therapies for patients with IBD.

Indexed as

Therapy with HelminthsAnimalsHelminthsHumansInflammatory Bowel Diseases

Identifiers

PMID23178819
PMCPMC3683647
OpenAlexW1980609624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.